**Core Concept**
The interaction between intravenous anaesthetic agents and tricyclic antidepressants involves the potentiation of the effects of the anaesthetic by the antidepressant, leading to increased risk of adverse effects such as respiratory depression, hypotension, and cardiac arrhythmias.

**Why the Correct Answer is Right**
Tricyclic antidepressants (TCAs) inhibit the cytochrome P450 enzyme system, particularly CYP2D6, which is responsible for the metabolism of many intravenous anaesthetic agents, including propofol. This inhibition leads to increased plasma concentrations and prolonged effects of the anaesthetic. Additionally, TCAs can also interact with the anaesthetic through their anticholinergic effects, which can potentiate the respiratory and cardiac effects of the anaesthetic.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect as there is no known interaction between this anaesthetic agent and TCAs.
* **Option B:** This option is incorrect as this anaesthetic agent is not commonly used in clinical practice, and its interaction with TCAs is not well-documented.
* **Option C:** This option is incorrect as this anaesthetic agent does not have a significant interaction with TCAs.

**Clinical Pearl / High-Yield Fact**
When prescribing intravenous anaesthetic agents to patients taking TCAs, it is essential to carefully monitor the patient's vital signs and adjust the anaesthetic dosage accordingly to minimize the risk of adverse effects.

**Correct Answer:** C. Etomidate is not a correct answer.